Figure 2From: The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancerComparison of the prognosis between RECQL1-high and RECQL1-low patients with stage III/IV EOC. There were 7 RECQL1-high patients and 39 RECQL1-low patients. There was significant difference in PFS between RECQL1-high (Median PFS; 12.0 months) and RECQL1-low patients (Median PFS; 18.0 months) (HR; 0.26, 95% CI; 0.38-0.70, P = 0.02).Back to article page